The impact of BRAF mutation status on clinical outcomes...

  • Main
  • 2020 / 10
  • The impact of BRAF mutation status on clinical outcomes...
Pigment Cell & Melanoma Research 2020 / 10

The impact of BRAF mutation status on clinical outcomes with anti‐PD‐1 monotherapy versus combination ipilimumab/nivolumab in treatment‐naïve advanced stage melanoma

Ma, Vincent T., Daignault‐Newton, Stephanie, Waninger, Jessica J., Journey, Sara, Chopra, Zoey, Tezel, Alangoya, Redman, Bruce G., Fecher, Leslie A., Green, Michael D., Alva, Ajjai S., Lao, Christop
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
Pigment Cell & Melanoma Research
DOI:
10.1111/pcmr.12944
Date:
October, 2020
File:
PDF, 12.79 MB
2020
Conversion to is in progress
Conversion to is failed